October 14, 2026
Dayne Rayford, Shivani Dayal, Kosu Boudreau et al.
preprint
Background and aimsPsilocybin can induce profound alterations in perception, emotion and self-referential processing. These changes are often accompanied by increased feelings of interpersonal connection, found via both psychometric survey data and anecdotally collected qualitative data. Despite recent increases in psychedelic research and treatment, most clinical trials have been performed in...
Frontiers in Neuroscience
2025
Christine Ramirez, Gertrude Asumpaame Alayine, Cyril Selase Kwaku Akafia et al.
3 citations
Anxiety and depression reduce autonomic system activity, as measured by Heart Rate Variability (HRV), and exacerbate cardiac morbidity. Both music and mindfulness have been shown to increase HRV, and clinical approaches incorporating these interventions show promise as effective treatments for symptoms of anxiety and depression. Music mindfulness, which combines music listening with mindfulness...
medRxiv
December 27, 2024
Eghosa Igbinobaro, Amanda Watts, Oluwatofunmi Oshodi et al.
preprint
Mental health disparities result from complex factors, including differential diagnoses, lack of access to standard mental health treatments, and inconsistent application of treatments when care is accessed. The COVID-19 pandemic exacerbated these disparities as marginalized groups had less access to testing and care while having higher infection rates. Community-based forms of care, such as...
Frontiers in Psychiatry
June 26, 2023
Simon Zhornitsky, Henrique Nunes Pereira Oliva, Laura A. Jayne et al.
12 citations
Background Ketamine and psychedelics have abuse liability. They can also induce “transformative experiences” where individuals experience enhanced states of awareness. This enhanced awareness can lead to changes in preexisting behavioral patterns which could be beneficial in the treatment of substance use disorders (SUDs). Preclinical and clinical studies suggest that ketamine and psychedelics...